Related Experiment Video
Updated: Jun 30, 2026

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
Published on: June 7, 2024
[NY-ESO-1 and cancer immunotherapy]
1Center of Hepatobiliary Surgery, Peking University People's Hospital, Beijing 100044, China.
Abstract:
NY-ESO-1 is an important member of cancer-testis antigen family and is widely distributed among many cancer types. As a tumor-specific antigen with the strongest immunogenicity so far identified, it can induce spontaneous antibody and T-cell responses in patients with NY-ESO-1-positive tumors. Therefore, it has been a good vaccine candidate in the immunotherapy against many malignancies. This article reviews the recent research advances in NY-ESO-1 and its relevant vaccines.
Insights
NY-ESO-1, a potent cancer-testis antigen, shows strong immunogenicity in NY-ESO-1-positive tumors. Research advances highlight its potential as a vaccine candidate for cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
Context:
- NY-ESO-1 is a prominent cancer-testis antigen found in various cancer types.
- It exhibits strong immunogenicity, triggering spontaneous immune responses in patients.
Purpose:
- To review recent research advances concerning NY-ESO-1.
- To explore the development of NY-ESO-1-based vaccines for cancer immunotherapy.
Summary:
- NY-ESO-1 is a tumor-specific antigen with significant immunogenic properties.
- It elicits antibody and T-cell responses in patients with NY-ESO-1-positive tumors.
- These characteristics make it a promising candidate for cancer vaccines.
Impact:
- Advances in understanding NY-ESO-1 contribute to novel immunotherapy strategies.
- NY-ESO-1 vaccines offer potential for treating a range of malignancies.
- This review provides insights into the evolving landscape of cancer vaccines.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
